AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AIM ImmunoTech Inc. Director's Dealing 2016

Mar 14, 2016

Director's Dealing

Opens in your device viewer

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2016-03-11

Reporting Person: Equels Thomas K. (Director, CEO,Pres,Exec Vice Chairman)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-11	Common Stock	P	30000	$0.1564	Acquired	1444548	Direct
2016-03-11	Common Stock	P	10000	$0.1618	Acquired	1454548	Direct

F1: To correct the amount of securities beneficially owned following the reported transaction.

F2: To correct the amount of securities beneficially owned following the reported transaction.